Congress delays Medicare efficiency cuts for physicians, cuts payment growth instead

What it does

This bill delays until January 1, 2030 a Medicare rule (finalized November 2025) that would adjust physician payment rates to account for efficiency gains in medical services. It requires the Secretary of Health and Human Services to study whether such an adjustment is necessary and, if implemented after 2030, imposes conditions: consultation with affected physician specialties, exemption for recently revalued services, and a one-time-only restriction. The bill also modifies the annual conversion factor updates for Medicare physician payments, reducing 2026 updates and setting 2027+ updates at 0.75% for qualifying APM providers and 0.25% for non-qualifying providers.

Why we flagged it

The bill's core function is to postpone a specific Medicare efficiency adjustment rule and modify physician conversion factor updates. It is a targeted payment-policy amendment, not a broad reform or appropriation.

What the text implies

• The 4-year delay (2026–2029) allows physician specialties to lobby for exemptions or modifications before 2030 implementation, potentially weakening the efficiency adjustment's scope or impact.
• The conversion factor reductions (0.75%–0.25% for 2027+) are substantially below historical Medicare payment updates and inflation, effectively cutting physician compensation growth independent of the efficiency adjustment delay.
• The bill conditions future efficiency adjustment implementation on a productivity-inflation comparison (APM conversion factor update ≥ CPI), creating a mechanism that may indefinitely block the adjustment if inflation remains elevated.
• Exempting services revalued within 10 years may protect high-volume, recently reviewed specialties while exposing older, less-reviewed services to larger adjustments, creating disparate payment impacts across medical fields.
• The study requirement (due 2 years post-enactment) and consultation mandate create procedural hurdles that may delay or prevent implementation even after January 1, 2030, effectively extending the moratorium.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The delay protects physicians from immediate payment reductions tied to efficiency adjustments, which may preserve access to care and physician participation in Medicare; however, it also defers cost-control measures that could reduce unnecessary healthcare spending and taxpayer burden. The lower conversion factor updates (0.75%–0.25% vs. historical levels) represent a real reduction in physician payment growth, offsetting the delay's benefit.

Who stands to gain

• physician practices and specialties (delayed payment reductions)
• healthcare providers billing Medicare (preserved reimbursement rates during delay period)

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS), Medicare, House Committee on Ways and Means, House Committee on Energy and Commerce, Senate Committee on Finance, physician specialties, APM (Advanced Payment Model) providers

Where it stands

14 cosponsors: 7 Democrats, 7 Republicans.

• Feb 12, 2026 — Introduced · Congress.gov: “Introduced in House”
• Feb 12, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

21 lobbying clients named this bill on 24 disclosure filings across 2 quarters, Mar 2026 to Jun 2026. Those filings disclosed $4,090,537 in lobbying spend. A filing names 16 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 97% of bills with at least one filing.

Ron Estes, the sponsor, reported $1,180,334 in PAC receipts in the 2026 cycle.

• American College of Cardiology — $680,000 on 1 filing
• American Academy of Dermatology Association — $580,000 on 1 filing
• College of American Pathologists — $486,008 on 2 filings
• American Society of Cataract & Refractive Surgery — $402,477 on 2 filings
• American Academy of Ophthalmology — $302,068 on 1 filing

Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.